AVAILABLE TO CLINICIANS ONLY

Releasing 01.03.2025

PRE-ORDER NOW

A world first in insulin testing

The future of exceptional metabolism

Early detection of T2DM and IR (MetS)

Early detection and management of conditions: Type 2 Diabetes, Obesity, Cardiovascular Disease, Polycystic Ovary Syndrome (PCOS), Non-Alcoholic Fatty Liver Disease (NAFLD), Hypertension, Dementia.

Cost effective community screening

By identifying insulin resistance early, it helps prevent the progression of these diseases, reducing long-term healthcare costs.

Realtime results for HOMA-IR and OGTT

Immediate measurement of insulin resistance and glucose tolerance. This real-time data enables your most accurate monitoring of metabolic health.

Unrivalled research data collation

Precise and continuous data collection that offers insights into metabolic health like never before. Track changes and identify early markers of insulin resistance years before glucose dys-regulation.